Pramlintide Acetate Injection — FDA Drug Shortage

No longer listed by FDA — AstraZeneca AB

The FDA lists a drug shortage record for Pramlintide Acetate Injection (injection) from AstraZeneca AB with status No longer listed by FDA. The shortage was first posted on Oct 27, 2025.

Shortage details

Status
No longer listed by FDA
Company
AstraZeneca AB
Package NDC
0310-6615-02
Dosage Form
Injection
Presentation
SymlinPen® 60 , Injection, 1000 ug/1 mL (NDC 0310-6615-02)
Initial Posting
Oct 27, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.